PGR Gene Fusions Identify a Molecular Subset of Uterine Epithelioid Leiomyosarcoma With Rhabdoid Features

Genetic aberrations among uterine epithelioid leiomyosarcomas are unknown. Following identification of an index case with NR4A3-PGR fusion demonstrating monomorphic morphologic features, we interrogated additional uterine tumors demonstrating similar histology and sought to describe the morphologic and immunohistochemical characteristics of PGR-rearranged sarcomas. Targeted next-generation RNA sequencing was performed on RNA extracted from formalin-fixed paraffin-embedded tissue of the index case. Fluorescence in situ hybridization using custom probes flanking PGR and NR4A3 genes was applied to 17 epithelioid leiomyosarcomas, 6 endometrial stromal tumors, and 3 perivascular epithelioid cell tumors. NR4A3-PGR fusion (n=4) and PGR rearrangement (n=2) were detected in 6 (35%) epithelioid leiomyosarcomas. Median patient age was 45 years, and all presented with FIGO stage I or II tumors, 2 being alive with disease at 75 and 180 months. All tumors were centered in the cervical stroma or myometrium and consisted of cells with abundant eosinophilic cytoplasm (epithelioid), including many displaying dense intracytoplasmic inclusions (rhabdoid). Myxoid matrix and hydropic change imparted a microcystic growth pattern in 4 tumors. Five also showed a minor spindle cell component which was low-grade in 3, consisting of bland spindle cells with low mitotic activity. High-grade spindle cell morphology was seen in 2 tumors, exhibiting a storiform pattern of atypical spindle cells associated with brisk mitotic activity. Desmin, estrogen receptor, and progesterone receptor were positive in all 6 tumors, while CD10 and HMB45 were negative. PGR rearrangements define a genetic subset of epithelioid leiomyosarcomas with often biphasic morphology consisting of epithelioid and rhabdoid as well as spindle cell components.

[1]  S. Yip,et al.  Novel EPC1 gene fusions in endometrial stromal sarcoma , 2018, Genes, chromosomes & cancer.

[2]  A. Drilon,et al.  Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations. , 2018, Cancer discovery.

[3]  M. Köbel,et al.  ALK Is a Specific Diagnostic Marker for Inflammatory Myofibroblastic Tumor of the Uterus , 2018, The American journal of surgical pathology.

[4]  M. Ladanyi,et al.  NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma , 2018, The American journal of surgical pathology.

[5]  L. Gorunova,et al.  Identification of an EPC2-PHF1 fusion transcript in low-grade endometrial stromal sarcoma , 2018, Oncotarget.

[6]  K. Giannikou,et al.  Expanding the histomorphologic spectrum of TFE3-rearranged perivascular epithelioid cell tumors. , 2018, Human pathology.

[7]  Funda Meric-Bernstam,et al.  Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children , 2018, The New England journal of medicine.

[8]  C. Antonescu,et al.  Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors , 2018, The American journal of surgical pathology.

[9]  J. Fletcher,et al.  BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas , 2017, The American journal of surgical pathology.

[10]  M. Ladanyi,et al.  ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity , 2017, Modern Pathology.

[11]  Y. Ishikawa,et al.  Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene. , 2017, Japanese journal of clinical oncology.

[12]  A. Chou,et al.  Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized , 2017, The American journal of surgical pathology.

[13]  E. Oliva,et al.  Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum , 2017, Modern Pathology.

[14]  M. Ladanyi,et al.  BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology , 2017, Modern Pathology.

[15]  Jen-Chieh Lee,et al.  Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1 , 2017, The American journal of surgical pathology.

[16]  A. D. Dei Tos,et al.  HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma , 2017, Genes, chromosomes & cancer.

[17]  A. Chinnaiyan,et al.  Next generation sequencing of extraskeletal myxoid chondrosarcoma , 2017, Oncotarget.

[18]  Xiaoyu Chen,et al.  Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications , 2016, Bioinform..

[19]  Adrian V. Lee,et al.  Comprehensive evaluation of fusion transcript detection algorithms and a meta-caller to combine top performing methods in paired-end RNA-seq data , 2015, Nucleic acids research.

[20]  Narasimhan P. Agaram,et al.  Dichotomy of Genetic Abnormalities in PEComas With Therapeutic Implications , 2015, The American journal of surgical pathology.

[21]  M. Hameed,et al.  TFE3 Translocation–associated Perivascular Epithelioid Cell Neoplasm (PEComa) of the Gynecologic Tract: Morphology, Immunophenotype, Differential Diagnosis , 2015, The American journal of surgical pathology.

[22]  D. Bell,et al.  High-grade Endometrial Stromal Sarcomas: A Clinicopathologic Study of a Group of Tumors With Heterogenous Morphologic and Genetic Features , 2014, The American journal of surgical pathology.

[23]  Rama R. Gullapalli,et al.  Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion. , 2014, Cancer genetics.

[24]  P. Picci,et al.  Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma. , 2014, The Journal of molecular diagnostics : JMD.

[25]  Samuel Singer,et al.  Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology. , 2014, Human pathology.

[26]  R. Sciot,et al.  Identification of a novel, recurrent MBTD1‐CXorf67 fusion in low‐grade endometrial stromal sarcoma , 2014, International journal of cancer.

[27]  P. D. Dal Cin,et al.  Perivascular Epithelioid Cell Neoplasm (PEComa) of the Gynecologic Tract: Clinicopathologic and Immunohistochemical Characterization of 16 Cases , 2014, The American journal of surgical pathology.

[28]  B. Bjerkehagen,et al.  Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22‐translocation , 2013, Genes, chromosomes & cancer.

[29]  Joshua M. Stuart,et al.  Integrated genomic characterization of endometrial carcinoma , 2013, Nature.

[30]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[31]  B. Bjerkehagen,et al.  Novel Fusion of MYST/Esa1-Associated Factor 6 and PHF1 in Endometrial Stromal Sarcoma , 2012, PloS one.

[32]  M. van de Rijn,et al.  The Clinicopathologic Features of YWHAE-FAM22 Endometrial Stromal Sarcomas: A Histologically High-grade and Clinically Aggressive Tumor , 2012, The American journal of surgical pathology.

[33]  Steven J. M. Jones,et al.  14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma , 2012, Proceedings of the National Academy of Sciences.

[34]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[35]  E. Oliva,et al.  Smooth muscle tumors of the uterus: a practical approach. , 2009, Archives of pathology & laboratory medicine.

[36]  N. Wake,et al.  Endometrial Stromal Sarcomas and Related High-grade Sarcomas: Immunohistochemical and Molecular Genetic Study of 31 Cases , 2008, The American journal of surgical pathology.

[37]  J. Albores–Saavedra,et al.  HMB-45 Reactivity in Conventional Uterine Leiomyosarcomas , 2007, The American journal of surgical pathology.

[38]  A. Chlumská,et al.  HMB45+ cells in mixed stromal‐smooth muscle tumour of the uterus , 2006, Histopathology.

[39]  M. Michal,et al.  HMB45+ Hyalinized Epithelioid Tumor of the Uterus Is Linked to Epithelioid Leiomyoma Rather Than to PEC-omas , 2001, International journal of surgical pathology.

[40]  J. Goldblum,et al.  Epithelioid smooth-muscle tumors of the uterus: a clinicopathologic study of 18 patients. , 1997, The American journal of surgical pathology.

[41]  R. Kurman,et al.  Mesenchymal tumors of the uterus VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear‐cell leiomyoma. A clinical and pathologic analysis of 26 cases , 1976, Cancer.

[42]  C. Kunder,et al.  ALK-rearranged Tumors Are Highly Enriched in the STUMP Subcategory of Uterine Tumors , 2019, The American journal of surgical pathology.

[43]  C. Antonescu,et al.  Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma , 2017, The American journal of surgical pathology.

[44]  A. Folpe,et al.  Perivascular epithelioid cell neoplasms: pathology and pathogenesis. , 2010, Human pathology.

[45]  B. Bjerkehagen,et al.  Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma. , 2006, Cancer research.

[46]  P. Clement,et al.  Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors. , 2002, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.